Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4343 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Uterine Cancer |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Uterine Cancer Peripheral Blood Mononuclear Cells are a heterogeneous immune cell population isolated from the peripheral blood of uterine cancer patients, consisting primarily lymphocytes (T cells, B cells, NK cells) and monocytes. Morphologically, PBMCs are typically round or oval. These cells mediate anti-tumor immune responses through cytotoxic T cells (CTLs) and NK cells. Conversely, regulatory T cells (Tregs) and tumor-associated macrophages (TAMs) may contribute immune escape and facillitate tumor progression. Studies have shown that the subpopulation ratio and functional status of PBMCs in patients with uterine cancer are significantly correlated with disease stage and prognosis.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Uterine Cancer Peripheral Blood Mononuclear Cells can be used to study the systemic immune status of patients with uterine cancer, including functional changes in T cells, B cells, NK cells, and monocytes, revealing the regulatory mechanism of the tumor microenvironment on the immune system.